Outcome of Chronic Myeloid Leukemia-Chronic Phase Patients Treated With Imatinib: A Local Experience.

CONCLUSION: After a median follow-up of 8 years, imatinib was found to induce long survival with manageable side effect in adult Saudi patients with CML-CP.
PMID: 29397347 [PubMed - as supplied by publisher]

Source: Clinical Lymphoma and Myeloma - January 31, 2018 Category: Cancer & Oncology Authors: Al-Amri AM Tags: Clin Lymphoma Myeloma Leuk Source Type: research